Keng Kiat Toh

Directeur/Membre du Conseil chez CYTOMED THERAPEUTICS LIMITED Fortune : 6 600 $ au 30/04/2024

Profil

Keng Kiat Toh is currently an Independent Director at CytoMed Therapeutics Ltd.
since 2023 and a Medical Director at Cryoviva Singapore Pte Ltd.
since 2017.
Previously, he served as a Medical Director at Cordlife Group Ltd.
from 2005 to 2008 and as an Associate Professor at Monash University Malaysia Sdn.
Bhd.
from 2007 to 2023.
He also held the position of Member-Parliament at the Government of Singapore from 1992 to 1994 and served as the President of Rotary International from 1998 to 1999.
Dr. Toh obtained his undergraduate degree from the National University of Singapore in 1965.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CYTOMED THERAPEUTICS LIMITED 0,03%	01/05/2023	3 000 ( 0,03% )	6 600 $	30/04/2024

Postes actifs de Keng Kiat Toh

Sociétés	Poste	Début
CYTOMED THERAPEUTICS LIMITED	Directeur/Membre du Conseil	18/04/2023
Cryoviva Singapore Pte Ltd.	Directeur Technique/Scientifique/R&D	01/08/2017

Anciens postes connus de Keng Kiat Toh

Sociétés	Poste	Fin
Monash University Malaysia Sdn. Bhd.	Corporate Officer/Principal	01/01/2023
CORDLIFE GROUP LIMITED	Directeur Technique/Scientifique/R&D	01/01/2008
Rotary International	President	01/01/1999
Government of Singapore	Corporate Officer/Principal	01/01/1994

Formation de Keng Kiat Toh

National University of Singapore

Undergraduate Degree